Shilajit is a safe, fluvic mineral complex exudate that is common to Ayurvedic medicine and is composed of fulvic acids, dibenzo-α-pyrones, proteins, and minerals. The purpose of this study was to examine the effects of 8 weeks of Shilajit supplementation at 250 mg·d− 1 (low dose) and 500 mg·d− 1 (high dose) versus placebo on maximal voluntary isometric contraction (MVIC) strength, concentric peak torque, fatigue-induced percent decline in strength, and serum hydroxyproline (HYP). Sixty-three recreationally-active men ( $$ \overline{X} $$ ± SD: 21.2 ± 2.4 yr.; 179.8 ± 6.3 cm; 83.1 ± 12.7 kg) volunteered to participate in this study. The subjects were randomly assigned to the high dose, low dose, or placebo group (each group: n = 21). During pre-supplementation testing, the subjects performed 2 pretest MVICs, 2 sets of 50 maximal, bilateral, concentric isokinetic leg extensions at 180°·s− 1 separated by 2-min of rest, and 2 posttest MVICs. Following 8 weeks of supplementation, the subjects repeated the pre-supplementation testing procedures. In addition, the groups were dichotomized at the 50th percentile based on pre-supplementation MVIC and baseline HYP. Mixed model ANOVAs and ANCOVAs were used to statistically analyze the dependent variables for the total groups (n = 21 per group) as well as dichotomized groups. For the upper 50th percentile group, the post-supplementation adjusted mean percent decline in MVIC was significantly less for the high dose group (8.9 ± 2.3%) than the low dose (17.0 ± 2.4%; p = 0.022) and placebo (16.0 ± 2.4%; p = 0.044) groups. There was no significant (p = 0.774) difference, however, between the low dose and placebo groups. In addition, for the upper 50th percentile group, the adjusted mean post-supplementation baseline HYP for the high dose group (1.5 ± 0.3 μg·mL− 1) was significantly less than both the low dose (2.4 ± 0.3 μg·mL− 1; p = 0.034) and placebo (2.4 ± 0.3 μg·mL− 1, p = 0.024) groups. The results of the present study demonstrated that 8 weeks of PrimaVie® Shilajit supplementation at 500 mg·d− 1 promoted the retention of maximal muscular strength following the fatiguing protocol and decreased baseline HYP. Thus, PrimaVie® Shilajit supplementation at 500 mg·d− 1 elicited favorable muscle and connective tissue adaptations.

There is conflicting evidence of the roles vitamin D and iron have in isolation and combined in relation to muscle health. The purpose of this narrative review was to examine the current literature on the roles that vitamin D and iron have on skeletal muscle mass, strength, and function and how these nutrients are associated with skeletal muscle health in specific populations. Secondary purposes include exploring if low vitamin D and iron status are interrelated with skeletal muscle health and chronic inflammation and reviewing the influence of animal-source foods rich in these nutrients on health and performance. PubMed, Scopus, SPORT Discus, EMBAE, MEDLINE, and Google Scholar databases were searched to determine eligible studies. There was a positive effect of vitamin D on muscle mass, particularly in older adults. There was a positive effect of iron on aerobic and anaerobic performance. Studies reported mixed results for both vitamin D and iron on muscle strength and function. While vitamin D and iron deficiency commonly occur in combination, few studies examined effects on skeletal muscle health and inflammation. Isolated nutrients such as iron and vitamin D may have positive outcomes; however, nutrients within food sources may be most effective in improving skeletal muscle health.

Previous studies have demonstrated that ayurvedic ingredients exhibit ergogenic (performance enhancing) properties, however, no previous studies have examined the ergogenic potential of Asparagus racemosus. The purpose of the present study was to examine the ergogenic efficacy of supplementation with 500 mg·d⁻¹ of A. racemosus during bench press training. Eighteen recreationally trained men (mean ± SD; age = 20.4 ± 0.5 yrs; height = 179.7 ± 1.5 cm; weight = 84.7 ± 5.7 kg) were randomly assigned either 500 mg·d⁻¹ of A. racemosus (n = 10) or placebo (n = 8). An overlapping sample of 10 participants were used to determine test-retest reliability. Pre- and post-training testing included bench press with one repetition maximum (1RM) and repetitions to failure at 70% of pre-training 1RM. The participants performed two sets of bench press to failure three times a week for eight weeks. Independent t-tests, Analyses of covariance (ANCOVA), and regression analyses were used to analyze the dependent variables. The results demonstrated greater mean percentage (14.3 ± 7.7% vs. 7.8 ± 4.5%; p = 0.048) and individual (80% vs. 50%) increases in 1RM, mean (17.5 ± 2.2 repetitions vs. 15.2 ± 2.2 repetitions; p = 0.044) and individual (80% vs. 38%) increases in repetitions to failure, and a greater rate of increase in training loads for the Asparagus racemosus group than the placebo group. In conjunction with bench press training, supplementation with A. racemosus provided ergogenic benefits compared to placebo.

The purposes of the present study were to apply a unique method for the identification of the time course of changes in neuromuscular responses and to infer the motor unit activation strategies used to maintain force during a fatiguing, intermittent isometric workbout. Eleven men performed 50, 6 s intermittent isometric muscle actions of the leg extensors, each separated by 2 s of rest at 60% maximal voluntary isometric contraction (MVIC). Electromyographic (EMG) and mechanomyographic (MMG) amplitude (root mean square; RMS) and frequency (mean power frequency; MPF) were obtained from the vastus lateralis (VL) every 5 of the 50 repetitions and normalized as a percent of the initial repetition. Polynomial regression analyses were used to determine the model of best fit for the normalized EMG RMS, EMG MPF, MMG RMS, and MMG MPF versus repetition relationships and one-way repeated measures ANOVAs with post-hoc Student Newman–Keuls were used to identify when these neuromuscular parameters changed from the initial repetition. The findings of the present study indicated two unique phases of neuromuscular responses (repetitions 1–20 and 20–50) during the fatiguing workbout. The time course of changes in these four neuromuscular responses suggested that the after-hyperpolarization theory could not explain the maintenance of force production, but Muscle Wisdom and the Onion Skin Scheme could. The findings of the current study suggested that the time course of changes in neuromuscular responses can provide insight in to the motor unit activation strategies used to maintain force production and allow for a greater understanding of the fatiguing process by identifying the time-points at which these neuromuscular parameters changed.